Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A0A3S7X362
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 103 | 105 | PF00675 | 0.619 |
CLV_NRD_NRD_1 | 164 | 166 | PF00675 | 0.698 |
CLV_NRD_NRD_1 | 193 | 195 | PF00675 | 0.556 |
CLV_NRD_NRD_1 | 77 | 79 | PF00675 | 0.471 |
CLV_PCSK_KEX2_1 | 103 | 105 | PF00082 | 0.615 |
CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.698 |
CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.599 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.471 |
CLV_PCSK_SKI1_1 | 115 | 119 | PF00082 | 0.679 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.497 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.548 |
DOC_MAPK_gen_1 | 164 | 171 | PF00069 | 0.678 |
DOC_MAPK_JIP1_4 | 165 | 171 | PF00069 | 0.640 |
DOC_PP2B_LxvP_1 | 160 | 163 | PF13499 | 0.589 |
DOC_PP2B_PxIxI_1 | 183 | 189 | PF00149 | 0.551 |
DOC_USP7_MATH_1 | 121 | 125 | PF00917 | 0.735 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.556 |
LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.612 |
LIG_14-3-3_CanoR_1 | 34 | 43 | PF00244 | 0.489 |
LIG_14-3-3_CanoR_1 | 60 | 66 | PF00244 | 0.449 |
LIG_AP2alpha_2 | 196 | 198 | PF02296 | 0.582 |
LIG_BRCT_BRCA1_1 | 15 | 19 | PF00533 | 0.622 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.599 |
LIG_FHA_2 | 137 | 143 | PF00498 | 0.678 |
LIG_FHA_2 | 187 | 193 | PF00498 | 0.553 |
LIG_LIR_Nem_3 | 51 | 56 | PF02991 | 0.569 |
LIG_NRBOX | 96 | 102 | PF00104 | 0.588 |
LIG_Pex14_2 | 59 | 63 | PF04695 | 0.413 |
LIG_REV1ctd_RIR_1 | 115 | 123 | PF16727 | 0.644 |
LIG_REV1ctd_RIR_1 | 50 | 58 | PF16727 | 0.519 |
LIG_SH2_CRK | 80 | 84 | PF00017 | 0.543 |
LIG_SH2_STAP1 | 75 | 79 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.494 |
LIG_SH3_3 | 150 | 156 | PF00018 | 0.572 |
LIG_SH3_3 | 160 | 166 | PF00018 | 0.577 |
LIG_SH3_3 | 55 | 61 | PF00018 | 0.511 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.657 |
MOD_CK2_1 | 136 | 142 | PF00069 | 0.621 |
MOD_CK2_1 | 186 | 192 | PF00069 | 0.550 |
MOD_Cter_Amidation | 101 | 104 | PF01082 | 0.623 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.703 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.516 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.756 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.596 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.621 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.469 |
MOD_N-GLC_1 | 124 | 129 | PF02516 | 0.603 |
MOD_N-GLC_1 | 14 | 19 | PF02516 | 0.629 |
MOD_N-GLC_1 | 34 | 39 | PF02516 | 0.329 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.568 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.426 |
MOD_PK_1 | 3 | 9 | PF00069 | 0.571 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.705 |
MOD_Plk_1 | 124 | 130 | PF00069 | 0.759 |
MOD_Plk_1 | 144 | 150 | PF00069 | 0.495 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.593 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.551 |
TRG_DiLeu_BaLyEn_6 | 89 | 94 | PF01217 | 0.548 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.457 |
TRG_ENDOCYTIC_2 | 85 | 88 | PF00928 | 0.402 |
TRG_ER_diArg_1 | 163 | 165 | PF00400 | 0.659 |
TRG_ER_diArg_1 | 77 | 79 | PF00400 | 0.471 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7F0 | Leptomonas seymouri | 77% | 100% |
A0A0S4JPS5 | Bodo saltans | 36% | 100% |
A0A1X0P291 | Trypanosomatidae | 55% | 100% |
A0A422NIE5 | Trypanosoma rangeli | 55% | 100% |
A4HI15 | Leishmania braziliensis | 88% | 100% |
A4I592 | Leishmania infantum | 99% | 100% |
C9ZQM3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
E9B0I9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
Q4Q7Q9 | Leishmania major | 97% | 100% |